The strict association between AD pathogenesis and the generation of oxidative stress (Cheignon et al. 2018), prompted us to investigate the impact of Oxo treatment on the modulation of Aβ-induced oxidative stress-related parameters, including ROS production and SOD activity. Here, SOD1 is linked to Alzheimer disease.